MeSH Review:
Plateletpheresis
Zimmermann,
Loew,
Weisbach,
Strasser,
Ringwald,
Zingsem,
Eckstein,
Koh,
Devendra,
Tien,
Zeiler,
Zingsem,
Moog,
Kretschmer,
Eckstein,
Müller,
Eisenbeisz,
Makar,
Butler,
Cockersole,
Gabra,
Serevitch,
Perseghin,
Mascaretti,
Speranza,
Belotti,
Baldini,
Dassi,
Riva,
Pogliani,
Sciorelli,
Bolan,
Cecco,
Wesley,
Horne,
Yau,
Remaley,
Childs,
Barrett,
Rehak,
Leitman,
- Reversible acute sensorineural hearing loss associated with essential thrombocytosis. Grisell, D.L., Mills, G.M. Arch. Intern. Med. (1986)
- Relationship of physical symptoms, ECG, free calcium, and other blood chemistries in reinfusion with citrated blood. Ladenson, J.H., Miller, W.V., Sherman, L.A. Transfusion (1978)
- National audit of citrate toxicity in plateletpheresis donors. Makar, Y.F., Butler, M.O., Cockersole, G.M., Gabra, G., Serevitch, J.M. Transfusion medicine (Oxford, England) (2002)
- Neurologic manifestations of essential thrombocythemia. Jabaily, J., Iland, H.J., Laszlo, J., Massey, E.W., Faguet, G.B., Brière, J., Landaw, S.A., Pisciotta, A.V. Ann. Intern. Med. (1983)
- Acquired von Willebrand's disease in the myeloproliferative syndrome. Budde, U., Schaefer, G., Mueller, N., Egli, H., Dent, J., Ruggeri, Z., Zimmerman, T. Blood (1984)
- Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism. Shults, C.W., Nasirian, F., Ward, D.M., Nakano, K., Pay, M., Hill, L.R., Haas, R.H. Neurology (1995)
- Stimulation of human gamma interferon production by diterpene esters. Yip, Y.K., Pang, R.H., Oppenheim, J.D., Nachbar, M.S., Henriksen, D., Zerebeckyj-Eckhardt, I., Vilcek, J. Infect. Immun. (1981)
- Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood. Zimmermann, R., Loew, D., Weisbach, V., Strasser, E., Ringwald, J., Zingsem, J., Eckstein, R. Transfusion (2005)
- Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans. Stohlawetz, P., Horvath, M., Pernerstorfer, T., Nguyen, H., Vondrovec, B., Robisch, A., Eichler, H.G., Spitzauer, S., Jilma, B. Transfusion (1999)
- Four pregnancies in two patients with essential thrombocythaemia--a case report. Koh, L.P., Devendra, K., Tien, S.L. Ann. Acad. Med. Singap. (2002)
- Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil-platelet aggregates. Stohlawetz, P., Kapiotis, S., Seidl, D., Hergovich, N., Zellner, M., Eichler, H.G., Stiegler, G., Leitner, G., Höcker, P., Jilma, B. Transfusion (1999)
- Paired plateletpheresis with the CS 3000 plus blood cell separator using the new 30 ml low-volume collection chamber and the A-35 collection chamber. Moog, R., Müller, N. Vox Sang. (1993)
- Humoral regulation of thrombopoiesis in man. Adams, W.H., Liu, Y.K., Sullivan, L.W. J. Lab. Clin. Med. (1978)
- Factors influencing the production of human immune interferon components. Van Damme, J., De Ley, M., Muylle, L., Billiau, A. Dev. Biol. Stand. (1983)
- Citrate anticoagulants for plateletpheresis. Huestis, D.W., Fletcher, J.L., White, R.F., Price, M.J. Transfusion (1977)
- Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Buchta, C., Bittner, C., Höcker, P., Macher, M., Schmid, R., Seger, C., Dettke, M. Transfusion (2003)
- Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators. Perseghin, P., Mascaretti, L., Speranza, T., Belotti, D., Baldini, V., Dassi, M., Riva, M., Pogliani, E.M., Sciorelli, G. Transfusion (2004)
- Purified human interleukin-2 enhances induction of immune interferon. Pearlstein, K.T., Palladino, M.A., Welte, K., Vilcek, J. Cell. Immunol. (1983)
- Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors. Benson, K., Marks, A.R., Marshall, M.J., Goldstein, J.D. Transfusion (1994)
- Flow cytometric analysis of platelet membrane antigens during and after continuous-flow plateletpheresis. Gutensohn, K., Bartsch, N., Kuehnl, P. Transfusion (1997)
- Single automated donor plateletpheresis increases the plasma level of proinflammatory cytokine tumor necrosis factor-alpha which does not associate with endothelial release markers von Willebrand factor and fibronectin. Karadoğan, I., Ozdoğan, M., Undar, L. Transfusion science. (2000)
- In vitro and in vivo comparison of single-donor platelets and multiple-donor pooled platelets transfusions in leukemic patients. Patel, I.P., Ambinder, E., Holland, J.F., Aledort, L.M. Transfusion (1978)
- Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation. Bolan, C.D., Cecco, S.A., Wesley, R.A., Horne, M., Yau, Y.Y., Remaley, A.T., Childs, R.W., Barrett, A.J., Rehak, N.N., Leitman, S.F. Transfusion (2002)
- Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis. Mercan, D., Bastin, G., Lambermont, M., Dupont, E. Transfusion (1997)
- Periodic alternating interface positioning to lower WBC contamination of apheresis platelet concentrates: a multicenter evaluation. Zeiler, T., Zingsem, J., Moog, R., Kretschmer, V., Eckstein, R., Müller, N., Eisenbeisz, F. Transfusion (2000)